Keywords: shire, focus, late-stage, acquisitions, profits, up, second

Shire to focus on late-stage acquisitions; profits up in second quarter

Article | 11 August 2003

Print This

Shire Pharmaceuticals, the UK's third largest drugmaker, says that it will dispose of its vaccines business and close its early-stage ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in